PROGNOSTIC METHODOLOGY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150292021A1
SERIAL NO

14238763

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention concerns a prognostic method for determining at least one, or a combination, of the following: time to first treatment, response to treatment or overall survival for a patient presenting with a disease including or characterised by telomere shortening, comprising an assessment of the longest mean telomere length at which telomere end-end fusion events can be detected and then a determination of the mean telomere length in the fusogenic range (i.e. the range below said mean telomere length at which telomere end-end fusion events can be detected) and the subsequent use of the mean telomere length in the fusogenic range as a prognostic indicator.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED30-36 NEWPORT ROAD CARDIFF CF24 0DE

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baird, Duncan Penarth, GB 5 7
Fegan, Christopher Cardiff, GB 4 5
Pepper, Chris Penarth, GB 11 211

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation